炎症相关外周血检测在癌症分期和预后中的预测价值
The Predictive Value of Inflammation-Related Peripheral Blood Measurements in Cancer Staging and Prognosis.
作者信息
Sylman Joanna L, Mitrugno Annachiara, Atallah Michelle, Tormoen Garth W, Shatzel Joseph J, Tassi Yunga Samuel, Wagner Todd H, Leppert John T, Mallick Parag, McCarty Owen J T
机构信息
VA Palo Alto Health Care System, Palo Alto, CA, United States.
Biomedical Engineering, School of Medicine, Oregon Health & Science University, Portland, OR, United States.
出版信息
Front Oncol. 2018 Mar 21;8:78. doi: 10.3389/fonc.2018.00078. eCollection 2018.
Abstract
In this review, we discuss the interaction between cancer and markers of inflammation (such as levels of inflammatory cells and proteins) in the circulation, and the potential benefits of routinely monitoring these markers in peripheral blood measurement assays. Next, we discuss the prognostic value and limitations of using inflammatory markers such as neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios and C-reactive protein measurements. Furthermore, the review discusses the benefits of combining multiple types of measurements and longitudinal tracking to improve staging and prognosis prediction of patients with cancer, and the ability of novel frameworks to leverage this high-dimensional data.
摘要
在本综述中，我们讨论了癌症与循环系统中炎症标志物（如炎症细胞和蛋白质水平）之间的相互作用，以及在末梢血检测中常规监测这些标志物的潜在益处。接下来，我们讨论了使用中性粒细胞与淋巴细胞比率、血小板与淋巴细胞比率以及C反应蛋白测量等炎症标志物的预后价值和局限性。此外，本综述还讨论了结合多种测量类型和纵向跟踪以改善癌症患者分期和预后预测的益处，以及新型框架利用这种高维数据的能力。
相似文献
1
The Predictive Value of Inflammation-Related Peripheral Blood Measurements in Cancer Staging and Prognosis.炎症相关外周血检测在癌症分期和预后中的预测价值
Front Oncol. 2018 Mar 21;8:78. doi: 10.3389/fonc.2018.00078. eCollection 2018.
2
Role of systemic inflammatory response markers in urological malignancy.全身炎症反应标志物在泌尿系统恶性肿瘤中的作用。
Int J Urol. 2019 Jan;26(1):31-47. doi: 10.1111/iju.13801. Epub 2018 Sep 25.
3
The preoperative neutrophil to lymphocyte ratio is a superior indicator of prognosis compared with other inflammatory biomarkers in resectable colorectal cancer.术前中性粒细胞与淋巴细胞比值是可切除结直肠癌预后的一个优于其他炎症生物标志物的指标。
BMC Cancer. 2017 Nov 10;17(1):744. doi: 10.1186/s12885-017-3752-0.
4
The prognostic value of systemic inflammation in patients undergoing surgery for colon cancer: comparison of composite ratios and cumulative scores.系统炎症对结肠癌手术患者的预后价值：复合比和累积评分的比较。
Br J Cancer. 2018 Jul;119(1):40-51. doi: 10.1038/s41416-018-0095-9. Epub 2018 May 23.
5
Systemic inflammation predicts all-cause mortality: a glasgow inflammation outcome study.全身炎症可预测全因死亡率：一项格拉斯哥炎症结局研究。
PLoS One. 2015 Mar 2;10(3):e0116206. doi: 10.1371/journal.pone.0116206. eCollection 2015.
6
Prognostic value of an inflammatory index for patients with metastatic castration-resistant prostate cancer.炎症指数对转移性去势抵抗性前列腺癌患者的预后价值。
Prostate. 2020 May;80(7):559-569. doi: 10.1002/pros.23969. Epub 2020 Mar 5.
7
Correlation of Inflammatory Markers, Survival, and COX2 Expression in Oral Cancer and Implications for Prognosis.口腔癌中炎症标志物的相关性、生存和 COX2 表达及其对预后的影响。
Otolaryngol Head Neck Surg. 2018 Apr;158(4):667-676. doi: 10.1177/0194599817745284. Epub 2018 Jan 23.
8
Application of platelet/lymphocyte and neutrophil/lymphocyte ratios in early diagnosis and prognostic prediction in patients with resectable gastric cancer.血小板/淋巴细胞比值和中性粒细胞/淋巴细胞比值在可切除胃癌患者早期诊断及预后预测中的应用
Cancer Biomark. 2015;15(6):899-907. doi: 10.3233/CBM-150534.
9
Prognostic value of neutrophil-lymphocyte ratio and level of C-reactive protein in a large cohort of pancreatic cancer patients: a retrospective study in a single institute in Japan.中性粒细胞与淋巴细胞比值及C反应蛋白水平在一大群胰腺癌患者中的预后价值：日本一家机构的回顾性研究
Jpn J Clin Oncol. 2015 Jan;45(1):61-6. doi: 10.1093/jjco/hyu159. Epub 2014 Oct 23.
10
Neutrophil-to-Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC) treated with nivolumab.中性粒细胞与淋巴细胞比值（NLR）和血小板与淋巴细胞比值（PLR）作为接受纳武单抗治疗的非小细胞肺癌（NSCLC）患者的预后标志物。
Lung Cancer. 2017 Sep;111:176-181. doi: 10.1016/j.lungcan.2017.07.024. Epub 2017 Jul 24.
引用本文的文献
1
Evaluation of the Prognostic Value of Obesity, Vitamin D Concentrations, and Systemic Inflammatory Response Indexes (SIRI, SII, PIV) in Patients With Breast Cancer Scheduled for Neoadjuvant Treatment.肥胖、维生素D浓度及全身炎症反应指标（SIRI、SII、PIV）对计划接受新辅助治疗的乳腺癌患者的预后价值评估
Breast Cancer (Auckl). 2025 Aug 25;19:11782234251369463. doi: 10.1177/11782234251369463. eCollection 2025.
2
Predictive value of inflammatory marker PLR in prostate cancer.炎症标志物血小板与淋巴细胞比值（PLR）在前列腺癌中的预测价值。
BMC Urol. 2025 Aug 2;25(1):188. doi: 10.1186/s12894-025-01882-9.
3
Prognostic impact of peripheral blood ratio in sinonasal squamous cell carcinoma.外周血比值在鼻窦鳞状细胞癌中的预后影响
Sci Prog. 2025 Jul-Sep;108(3):368504251364321. doi: 10.1177/00368504251364321. Epub 2025 Jul 29.
4
Correlation between neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio with prognosis in gastric cancer patients undergoing neoadjuvant chemotherapy: a meta-analysis.接受新辅助化疗的胃癌患者中性粒细胞与淋巴细胞比值和血小板与淋巴细胞比值与预后的相关性：一项荟萃分析
BMC Gastroenterol. 2025 Jul 1;25(1):445. doi: 10.1186/s12876-025-04056-x.
5
Revolutionizing breast cancer monitoring: emerging hematocrit-based metrics - a narrative review.革新乳腺癌监测：基于血细胞比容的新兴指标——一篇叙述性综述
Ann Med Surg (Lond). 2025 May 21;87(6):3327-3338. doi: 10.1097/MS9.0000000000003020. eCollection 2025 Jun.
6
Association of serum carotenoids and SII among general people, based on NHANES 2001-2006.基于2001 - 2006年美国国家健康与营养检查调查（NHANES）的普通人群血清类胡萝卜素与全身炎症反应指数（SII）的关联
Sci Rep. 2025 Mar 24;15(1):10107. doi: 10.1038/s41598-025-94594-x.
7
The value of peripheral blood inflammation markers in risk assessment and prediction of lung cancer.外周血炎症标志物在肺癌风险评估和预测中的价值。
Future Sci OA. 2025 Dec;11(1):2476870. doi: 10.1080/20565623.2025.2476870. Epub 2025 Mar 13.
8
Risk Factors Associated with Oral Intake Discontinuation in Hospitalized Patients with Aspiration Pneumonia: A Scoping Review.吸入性肺炎住院患者经口摄入中断的相关危险因素：一项范围综述
JMA J. 2025 Jan 15;8(1):11-17. doi: 10.31662/jmaj.2024-0077. Epub 2024 Dec 20.
9
Association between systemic immune-inflammation index and the risk of all-cause, cancer and non-cancer mortality in the general population: results from national health and nutrition examination survey 2005-2018.一般人群中全身免疫炎症指数与全因、癌症和非癌症死亡风险的关联：2005 - 2018年美国国家健康与营养检查调查结果
BMC Public Health. 2025 Jan 20;25(1):227. doi: 10.1186/s12889-025-21423-1.
10
Association between systemic immune inflammation index and cataract incidence from 2005 to 2008.2005年至2008年全身免疫炎症指数与白内障发病率之间的关联。
Sci Rep. 2025 Jan 2;15(1):499. doi: 10.1038/s41598-024-84204-7.
本文引用的文献
1
Platelet count as a predictor of metastasis and venous thromboembolism in patients with cancer.血小板计数作为癌症患者转移和静脉血栓栓塞的预测指标。
Converg Sci Phys Oncol. 2017 Jun;3(2). doi: 10.1088/2057-1739/aa6c05. Epub 2017 May 17.
2
The prognostic value of preoperative neutrophils, platelets, lymphocytes, monocytes and calculated ratios in patients with laryngeal squamous cell cancer.术前中性粒细胞、血小板、淋巴细胞、单核细胞及计算比值在喉鳞状细胞癌患者中的预后价值。
Oncotarget. 2017 Mar 15;8(36):60514-60527. doi: 10.18632/oncotarget.16234. eCollection 2017 Sep 1.
3
Doctor AI: Predicting Clinical Events via Recurrent Neural Networks.人工智能医生：通过循环神经网络预测临床事件
JMLR Workshop Conf Proc. 2016 Aug;56:301-318. Epub 2016 Dec 10.
4
The diagnostic efficacy of platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio in ovarian cancer.血小板与淋巴细胞比值及中性粒细胞与淋巴细胞比值在卵巢癌中的诊断效能
Inflamm Res. 2017 Jun;66(6):467-475. doi: 10.1007/s00011-017-1026-6. Epub 2017 Mar 4.
5
Relationships between longitudinal neutrophil to lymphocyte ratios, body weight changes, and overall survival in patients with non-small cell lung cancer.非小细胞肺癌患者中性粒细胞与淋巴细胞纵向比值、体重变化与总生存期之间的关系
BMC Cancer. 2017 Feb 16;17(1):141. doi: 10.1186/s12885-017-3122-y.
6
Systemic Immunity Is Required for Effective Cancer Immunotherapy.有效的癌症免疫疗法需要全身免疫。
Cell. 2017 Jan 26;168(3):487-502.e15. doi: 10.1016/j.cell.2016.12.022. Epub 2017 Jan 19.
7
Aspirin therapy reduces the ability of platelets to promote colon and pancreatic cancer cell proliferation: Implications for the oncoprotein c-MYC.阿司匹林疗法降低血小板促进结肠和胰腺癌细胞增殖的能力：对癌蛋白c-MYC的影响。
Am J Physiol Cell Physiol. 2017 Feb 1;312(2):C176-C189. doi: 10.1152/ajpcell.00196.2016. Epub 2016 Nov 30.
8
Prediagnostic Body Mass Index Trajectories in Relation to Prostate Cancer Incidence and Mortality in the PLCO Cancer Screening Trial.前列腺、肺癌、结直肠癌和卵巢癌（PLCO）癌症筛查试验中，诊断前体重指数轨迹与前列腺癌发病率和死亡率的关系
J Natl Cancer Inst. 2016 Oct 20;109(3). doi: 10.1093/jnci/djw225. Print 2017 Mar.
9
Neutrophil to Lymphocyte Ratio (NLR) and Derived Neutrophil to Lymphocyte Ratio (d-NLR) Predict Non-Responders and Postoperative Complications in Patients Undergoing Radical Surgery After Neo-Adjuvant Radio-Chemotherapy for Rectal Adenocarcinoma.中性粒细胞与淋巴细胞比值（NLR）及衍生中性粒细胞与淋巴细胞比值（d-NLR）可预测接受新辅助放化疗后行根治性手术的直肠癌患者的无反应者及术后并发症。
Cancer Invest. 2016;34(9):440-451. doi: 10.1080/07357907.2016.1229332. Epub 2016 Oct 14.
10
The Prognostic Role of the Platelet-Lymphocytes Ratio in Gastric Cancer: A Meta-Analysis.血小板-淋巴细胞比值在胃癌中的预后作用：一项荟萃分析
PLoS One. 2016 Sep 29;11(9):e0163719. doi: 10.1371/journal.pone.0163719. eCollection 2016.
Zotero 插件